Charles Schwab’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-992
| Closed | -$37K | – | 3570 |
|
2022
Q1 | $37K | Hold |
992
| – | – | ﹤0.01% | 3558 |
|
2021
Q4 | $54K | Sell |
992
-143
| -13% | -$7.78K | ﹤0.01% | 3505 |
|
2021
Q3 | $84K | Buy |
1,135
+35
| +3% | +$2.59K | ﹤0.01% | 3394 |
|
2021
Q2 | $925K | Buy |
+1,100
| New | +$925K | ﹤0.01% | 2959 |
|
2020
Q2 | – | Sell |
-136
| Closed | -$63K | – | 3332 |
|
2020
Q1 | $63K | Hold |
136
| – | – | ﹤0.01% | 3140 |
|
2019
Q4 | $28K | Hold |
136
| – | – | ﹤0.01% | 3147 |
|
2019
Q3 | $34K | Hold |
136
| – | – | ﹤0.01% | 3137 |
|
2019
Q2 | $341K | Buy |
136
+10
| +8% | +$25.1K | ﹤0.01% | 2973 |
|
2019
Q1 | $513K | Buy |
126
+23
| +22% | +$93.6K | ﹤0.01% | 2760 |
|
2018
Q4 | $318K | Hold |
103
| – | – | ﹤0.01% | 2916 |
|
2018
Q3 | $604K | Buy |
103
+23
| +29% | +$135K | ﹤0.01% | 2772 |
|
2018
Q2 | $280K | Hold |
80
| – | – | ﹤0.01% | 2998 |
|
2018
Q1 | $355K | Hold |
80
| – | – | ﹤0.01% | 2827 |
|
2017
Q4 | $307K | Buy |
80
+43
| +116% | +$165K | ﹤0.01% | 2868 |
|
2017
Q3 | $171K | Hold |
37
| – | – | ﹤0.01% | 3030 |
|
2017
Q2 | $165K | Buy |
+37
| New | +$165K | ﹤0.01% | 3056 |
|